首页> 外文OA文献 >Primjena sinbiotika u prijeoperacijskoj pripremi bolesnika za elektivnu operaciju debeloga crijeva Synbiotics application in the preoperative preparation of patients forudelective colorectal cancer surgery
【2h】

Primjena sinbiotika u prijeoperacijskoj pripremi bolesnika za elektivnu operaciju debeloga crijeva Synbiotics application in the preoperative preparation of patients forudelective colorectal cancer surgery

机译:合生元在术前患者准备选择性肠道手术中的应用synbiotics在术前准备患者中的应用 ud选择性结直肠癌手术

摘要

AIM: The aim of our study was to demonstrate higher concentration of lactic acid bacteriaud(LAB) at the colonic mucosa in patients treated with oral intake of synbiotics. We also tried toudprove that the systemic inflammatory response after surgery is less severe in patients whoudeither took synbiotics or prebiotics and that these patients have less postoperativeudcomplications and a favorable postoperative course. ----- METHODS: 73 patients with preceding colorectal operations were recruited. They wereudrandomized into three groups. One group received preoperatively prebiotics, the secondudsynbiotics in and third was preoperatively cleansed. We have defined the number of fouruddifferent probiotic bacteria on colonic mucosa with polymerase chain reaction(PCR). Serumudlevels of interleukin-6, CRP, fibrinogen, white cell count and differential blood count wereudmeasured pre- and postoperatively to determine systemic inflammatory response. ----- RESULTS: We found out that in the synbiotic group there were considerably more LABudpresented on the mucosa. They did pass the upper gastrointestinal tract and were isolated inudcolonic mucosa. On the other hand, we did not find any statistical differences in systemicudinflammatory response measured by upper factors and no differences in postoperative courseudand complications rate between all three groups. ----- CONCLUSIONS: LAB used in our study reach the large bowel mucosa after oral intake butudin our case that didn’t seem to have an effect on postoperative course following colorectaludsurgery for cancer.
机译:目的:我们的研究目的是证明口服合生素治疗的患者结肠黏膜中乳酸菌的浓度较高。我们还试图证明,服用过合生元或益生元的患者手术后的全身炎症反应较轻,这些患者的术后并发症较少,术后病程也较好。 -----方法:招募了73例大肠癌手术患者。他们被随机分为三组。一组在术前接受了益生元,第二和第二次使用了联糖合剂。通过聚合酶链反应(PCR),我们确定了结肠黏膜上四种不同的益生菌的数量。术前和术后均测量血清白细胞介素6,CRP,纤维蛋白原,白细胞计数和血细胞计数,以测定全身炎症反应。 -----结果:我们发现在合生元组中,黏膜上的LAB含量较高。他们确实通过了上消化道,并在粘膜粘膜中被隔离。另一方面,我们没有发现由上位因素测得的全身炎症反应的统计学差异,并且三组之间的术后病程/并发症发生率也没有差异。结论:我们的研究中使用的LAB口服后到达大肠粘膜,但是在我们的病例中,它似乎对结直肠癌/肿瘤外科手术后的病程没有影响。

著录项

  • 作者

    Krebs Bojan;

  • 作者单位
  • 年度 2014
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号